BioSpace News Archive

Pharm Country

Immunic to Participate in Industry and Scientific Conferences in July 2022

Immunic, Inc., a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced participation in the following industry and scientific conferences in July.

June 28, 2022
·
5 min read
Pharm Country

Boehringer Ingelheim and BiomX Collaborate to Discover Inflammatory Bowel Disease Microbiome Biomarkers

BiomX Inc. announces a new collaboration with Boehringer Ingelheim to identify biomarkers for inflammatory bowel disease.

June 28, 2022
·
4 min read
BioMidwest

Zomedica Announces Designation of PulseVet(R) System as the Official Shock Wave Therapy Supplier of the United States Equestrian Team

Zomedica Corp. is honored to announce that the United States Equestrian Federation has named PulseVet as the Official Shock Wave Therapy Supplier of US Equestrian Team Veterinarians.

June 28, 2022
·
6 min read
Bio NC

Asensus Surgical to Showcase the Senhance Surgical System and Performance-Guided Surgery in Upcoming Society of Robotic and Digital Surgery Conference

Asensus Surgical, Inc. announced the Company will be participating in the Society of Robotic and Digital Surgery Conference from June 30, 2022 until July 3, 2022 in Lake Buena Vista, Florida.

June 28, 2022
·
5 min read
Biotech Beach

Evofem Reaches Agreement with One of the Largest Pharmacy Benefit Managers in the U.S. for Access to Phexxi®

Evofem Biosciences, Inc., announced it has reached an agreement with one of the nation’s largest pharmacy benefit managers to ensure most women covered by this plan can fill their Phexxi® prescriptions for pregnancy prevention, without restrictions such as prior authorization or step therapy.

June 28, 2022
·
5 min read
BioCapital

Graybug Announces Review of Strategic Alternatives

Graybug Vision, Inc. announced that its Board of Directors will conduct a comprehensive review of strategic alternatives focused on maximizing shareholder value.

June 28, 2022
·
4 min read
Seegene develops PCR test to detect monkeypox virus

Assay targets monkeypox virus and can deliver results in 90 minutes Company swiftly rolls out product using its automated assay development system “Seegene will strive to make accurate tests for emerging viruses to help prevent future pandemics.”

June 28, 2022
·
1 min read
Drug Development

Oncolytics Biotech® Achieves Success Criteria for Efficacy in the Pancreatic Cancer Cohort of GOBLET

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that the pancreatic cancer cohort of the multi-indication phase 1/2 GOBLET study has met the efficacy expansion criteria for Stage 1 of the trial.

June 28, 2022
·
10 min read
Chemomab Awarded New U.S. Patent for CM-101, Its First-in-Class CCL24 Neutralizing Antibody

Chemomab Therapeutics, Ltd. today reported that the United States Patent and Trademark Office has issued a new patent for CM-101, Chemomab’s first-in-class monoclonal antibody that neutralizes CCL24, a novel disease target at the confluence of fibrosis and inflammation.

June 28, 2022
·
6 min read
Business

BioLineRx Announces Collaboration Agreement with GenFleet Therapeutics to Further Develop Motixafortide in Pancreatic Ductal Adenocarcinoma (PDAC)

GenFleet to design and execute randomized Phase 2b triple combination trial of Motixafortide in first-line metastatic PDAC patients in China.

June 28, 2022
·
9 min read